a renewed push to get prescribers to avoid ORAL diclofenac (Cataflam, Voltaren, etc) for treating inflammation and pain
July 2013
You'll see a renewed push to get prescribers to avoid ORAL diclofenac (Cataflam, Voltaren, etc) for treating inflammation and pain.
That's because diclofenac increases the risk of heart attacks.
Think of it as a "three-strikes" NSAID.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote